Fmr LLC Cognition Therapeutics Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Fmr LLC holds 101 shares of CGTX stock, worth $61. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101

Previous 1 10000.0%

Holding current value

$61

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	$1.66 - $2.62 $166 - $262	100 Added 10000.0%	101 $0
Q1 2023 May 11, 2023	BUY	$1.51 - $2.3 $1 - $2	1 New	1 $0

Others Institutions Holding CGTX

# of Institutions

Shares Held

7.62M

Call Options Held

Put Options Held

Pathstone Family Office, LLC Englewood, NJ

2.21M
Shares

$1.35 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.15M
Shares

$700,007
0.0% of portfolio
Awm Investment Company, Inc. New York, NY

650K
Shares

$396,500
0.17% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

500K
Shares

$305,000
0.01% of portfolio
Timelo Investment Management Inc.

361K
Shares

$220,452
0.35% of portfolio

View Full List

About COGNITION THERAPEUTICS INC

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $13.9M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

More about CGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account